journal article·2003-07-15

Glutaraldehyde‐fixed kangaroo aortic wall tissue: Histology, crosslink stability and calcification potential

W. M. L. Neethling, A. J. Hodge, R. Glancy

Publisher page

Abstract

Abstract Stentless aortic heart valve substitutes, manufactured from biological tissues, are fixed with glutaraldehyde to cross‐link collagen, reduce antigenicity, and sterilize the tissue. Despite improved cross linking, reduced antigenicity, and various anticalcification measures, the aortic wall tissue present in these prostheses tends to calcify. The aim of this study was to assess the morphology, collagen cross‐link stability, and calcification potential of glutaraldehyde‐preserved kangaroo aortic wall tissue as opposed to porcine aortic wall tissue. Porcine and kangaroo aortic wall tissues were fixed in 0.625% buffered glutaraldehyde. Histology and cross‐link stability were examined. Calcification potential was determined in the subcutaneous rat model. Kangaroo aortic wall tissue was significantly (p < 0.01) less calcified than porcine aortic wall tissue (26.67 ± 6.53 versus 41.959 ± 2.75 μg/mg tissue) at 8 weeks. In conclusion, the histological differences between kangaroo and porcine aortic wall tissue correlate well with the reduced calcification potential of kangaroo aortic wall tissue. The reduced calcification potential could result in improved long‐term durability of stentless kangaroo heart valves as bioprostheses. © 2003 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 66B: 356–363, 2003
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Cardiac Valve Diseases and Treatments · Electrospun Nanofibers in Biomedical Applications · Aortic Disease and Treatment Approaches

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (42)

Show source-provided references
1. 10.1136/thx.34.2.16610.1136/thx.34.2.166 ↗
2. 10.1016/0142-9612(96)82721-910.1016/0142-9612(96)82721-9 ↗
3. 10.1002/jbm.82024090510.1002/jbm.820240905 ↗
4. The role of glutaraldehyde‐induced crosslinks in calcification of bovine pericardium used in cardiac valve bioprostheses
5. 10.1002/(SICI)1097-4636(19970315)34:4<411::AID-JBM2>3.0.CO;2-N10.1002/(SICI)1097-4636(19970315)34:4<411::AID-JBM2>3.0.CO;2-N ↗
6. Prevention of leaflet calcification of bioprosthetic heart valves with diphosphonate injection therapy10.1016/S0022-5223(19)36218-X ↗
7. 10.1002/jbm.82025080210.1002/jbm.820250802 ↗
8. 10.1016/0003-4975(92)91321-Y10.1016/0003-4975(92)91321-Y ↗
9. 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O ↗
10. A quantitative study of calcium deposition in the aortic wall following Medtronic Freestyle compared with homograft aortic root replacement. A prospective randomized trial
11. Kangaroo versus porcine aortic valve tissue—Valvegeometry, morphology, tensile strength and calcification potential
12. 10.1111/j.1540-8191.2001.tb00540.x10.1111/j.1540-8191.2001.tb00540.x ↗
13. 10.1039/p1976000095810.1039/p19760000958 ↗
14. Improved ultrastructural preservation of bioprosthetic tissue
15. Use of glutaraldehyde and formaldehyde to process tissue heart valves
16. 10.1016/0021-9150(70)90063-810.1016/0021-9150(70)90063-8 ↗
17. 10.1016/0003-9861(61)90291-010.1016/0003-9861(61)90291-0 ↗
18. 10.1016/0014-4835(84)90053-810.1016/0014-4835(84)90053-8 ↗
19. 10.1016/0022-2836(68)90086-710.1016/0022-2836(68)90086-7 ↗
20. 10.1002/(SICI)1097-4636(199810)42:1<30::AID-JBM5>3.0.CO;2-P10.1002/(SICI)1097-4636(199810)42:1<30::AID-JBM5>3.0.CO;2-P ↗
21. 10.1016/S0022-5223(19)42561-010.1016/S0022-5223(19)42561-0 ↗
22. 10.3109/0300820850915238910.3109/03008208509152389 ↗
23. Explanted bio‐ prosthetic heart valves: Crosslinks and calcium analysis
24. 10.1016/0002-9149(84)90638-610.1016/0002-9149(84)90638-6 ↗
25. Biomaterial ‐associated calcification. Pathology, mechanism, and strategies for prevention
26. 10.1016/S0003-4975(10)61554-810.1016/S0003-4975(10)61554-8 ↗
27. 10.1097/00002480-199609000-0004810.1097/00002480-199609000-00048 ↗
28. 10.1111/j.1525-1594.1992.tb00532.x10.1111/j.1525-1594.1992.tb00532.x ↗
29. Processing factors as determinants of tissue valve calcification
30. 10.1161/01.CIR.95.2.47910.1161/01.CIR.95.2.479 ↗
31. 10.1161/01.CIR.90.1.32310.1161/01.CIR.90.1.323 ↗
32. Deformation of the stentless porcine valve scaffold enhances accelerated leaflet fibrosis and calcification in juvenile sheep
33. Feasibility evaluation of a new pericardial bioprosthesis with dye mediated photo‐oxidized bovine pericardial tissue
34. Reducing the variability in durability of heart valve bioprostheses
35. Heidemann E · 1993
36. 10.1002/jbm.82028060410.1002/jbm.820280604 ↗
37. 10.1002/(SICI)1097-4636(19990915)46:4<531::AID-JBM11>3.0.CO;2-210.1002/(SICI)1097-4636(19990915)46:4<531::AID-JBM11>3.0.CO;2-2 ↗
38. 10.1111/j.1525-1594.1992.tb00308.x10.1111/j.1525-1594.1992.tb00308.x ↗
39. 10.1002/jbm.1007710.1002/jbm.10077 ↗
40. 10.1002/1097-4636(200107)56:1<56::AID-JBM1068>3.0.CO;2-310.1002/1097-4636(200107)56:1<56::AID-JBM1068>3.0.CO;2-3 ↗
41. 10.1002/(SICI)1097-4636(19970615)35:4<531::AID-JBM13>3.0.CO;2-E10.1002/(SICI)1097-4636(19970615)35:4<531::AID-JBM13>3.0.CO;2-E ↗
42. Glutaraldehyde detoxification in addition to enhanced amine cross‐linking dramatically reduces bioprosthetic tissue calcification in the rat model